Barbara Castagnari
About
In The Last Decade
Barbara Castagnari
14 papers receiving 220 citations
Peers
Comparison fields: 5 of 44
- Hematology 124
- Immunology 74
- Molecular Biology 70
- Oncology 54
- Cancer Research 36
Countries citing papers authored by Barbara Castagnari
This map shows the geographic impact of Barbara Castagnari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Castagnari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Castagnari more than expected).
Fields of papers citing papers by Barbara Castagnari
This network shows the impact of papers produced by Barbara Castagnari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Castagnari. The network helps show where Barbara Castagnari may publish in the future.
Co-authorship network of co-authors of Barbara Castagnari
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Castagnari. A scholar is included among the top collaborators of Barbara Castagnari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Castagnari. Barbara Castagnari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 27 | |
| 3 | 14 | |
| 4 | 35 | |
| 5 | 14 | |
| 6 | CD116 (granulocyte-macrophage colony stimulating factor receptor). | 4 |
| 7 | 12 | |
| 8 | Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts. | 20 |
| 9 | 35 | |
| 10 | Flow cytometry measurement of cytokine receptors in acute leukemias. Clinical and biologic implications. | 1 |
| 11 | 38 | |
| 12 | Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction. | 10 |
| 13 | Flow cytometry evaluation of urokinase-type plasminogen activator receptor (UPA-R) in acute myeloid leukemia cells. | 3 |
| 14 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.